Correlation Between Takeda Pharmaceutical and Dakshidin

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Dakshidin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Dakshidin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical Co and Dakshidin Corporation, you can compare the effects of market volatilities on Takeda Pharmaceutical and Dakshidin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Dakshidin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Dakshidin.

Diversification Opportunities for Takeda Pharmaceutical and Dakshidin

-0.88

Correlation Coefficient

Takeda Pharmaceutical  Dakshidin

Pay attention - limited upside

The 3 months correlation between Takeda and Dakshidin is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Dakshidin Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dakshidin and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Dakshidin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dakshidin has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Dakshidin go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Dakshidin

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Dakshidin. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 10.26 times less risky than Dakshidin. The stock trades about -0.05 of its potential returns per unit of risk. The Dakshidin Corporation is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.12  in Dakshidin Corporation on September 4, 2024 and sell it today you would earn a total of  0.02  from holding Dakshidin Corporation or generate 16.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical Co  vs.  Dakshidin Corp.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Dakshidin

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dakshidin Corporation are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Dakshidin exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and Dakshidin

The main advantage of trading using opposite Takeda Pharmaceutical and Dakshidin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Dakshidin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dakshidin will offset losses from the drop in Dakshidin's long position.

The idea behind Takeda Pharmaceutical Co and Dakshidin Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.